Ausgabe 9/2014
Inhalt (10 Artikel)
Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography
Michael R Misch, Sara Mitchell, Philip L Francis, Kayla Sherborn, Katayoun Meradje, Alicia A McNeely, Kie Honjo, Jiali Zhao, Christopher JM Scott, Curtis B Caldwell, Lisa Ehrlich, Prathiba Shammi, Bradley J MacIntosh, Juan M Bilbao, Anthony E Lang, Sandra E Black, Mario Masellis
Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test
Tanis J Ferman, Glenn E Smith, Dennis W Dickson, Neill R Graff-Radford, Siong-Chi Lin, Zbigniew Wszolek, Jay A Van Gerpen, Ryan Uitti, David S Knopman, Ronald C Petersen, Joseph E Parisi, Michael H Silber, Bradley F Boeve
Expression of one important chaperone protein, heat shock protein 27, in neurodegenerative diseases
Xuekai Zhang, Jing Shi, Jinzhou Tian, Andrew C Robinson, Yvonne S Davidson, David M Mann
BrainCheck - a very brief tool to detect incipient cognitive decline: optimized case-finding combining patient- and informant-based data
Michael M Ehrensperger, Kirsten I Taylor, Manfred Berres, Nancy S Foldi, Myriam Dellenbach, Irene Bopp, Gabriel Gold, Armin von Gunten, Daniel Inglin, René Müri, Brigitte Rüegger, Reto W Kressig, Andreas U Monsch
Applying a cumulative deficit model of frailty to dementia: progress and future challenges
Kaarin J Anstey, Roger A Dixon
Quantitative neuropathological assessment to investigate cerebral multi-morbidity
Johannes Attems, Janna H Neltner, Peter T Nelson
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Elisabeth CW van Straaten, Philip Scheltens, Alida A Gouw, Cornelis J Stam
Imaging endpoints for clinical trials in Alzheimer’s disease
David M Cash, Jonathan D Rohrer, Natalie S Ryan, Sebastien Ourselin, Nick C Fox